CORONAVIRUS/WHO selects Taiwan's Medigen COVID-19 vaccine for international trial
10/26/2021 10:46 PM
Taipei, Oct. 26 (CNA) A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan aims to remove mask mandate on public transport by late AprilTaiwan's Central Epidemic Command Center (CECC) said Thursday that it is looking to lift the facemask mandate on public transportation by mid to late April if the COVID-19 ...03/23/2023 10:33 PM
- Regular COVID-19 testing to stop at some residential care facilitiesTaiwan's Central Epidemic Command Center (CECC) announced Thursday that three types of residential care facilities will not have to administer regular rapid tests for COVID-19 ...03/23/2023 06:17 PM
- Taiwan reports 5,544 new COVID-19 cases, 28 deathsTaiwan's Central Epidemic Command Center (CECC) on Monday reported 5,544 new cases of COVID-19 and 28 deaths from the disease.03/20/2023 05:12 PM
Latest
- Politics
Taiwan has tried its best to aid Honduras: MOFA
03/25/2023 02:23 PM - Business
January-February winning uniform invoice numbers released
03/25/2023 01:21 PM - Society
Taiwan headline news
03/25/2023 12:04 PM - Business
U.S. dollar higher in Taipei trading
03/25/2023 10:40 AM - Business
Taiwan's February unemployment rate hits 23-year low
03/24/2023 11:25 PM